Insider Transactions in Q1 2023 at Arcellx, Inc. (ACLX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 09
2023
|
Rami Elghandour |
SELL
Open market or private sale
|
Direct |
31,442
-44.78%
|
$943,260
$30.77 P/Share
|
|
Feb 09
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,966
-30.88%
|
$208,980
$30.77 P/Share
|
|
Feb 07
2023
|
Rami Elghandour |
BUY
Exercise of conversion of derivative security
|
Direct |
70,211
+50.0%
|
-
|
|
Feb 07
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
22,555
+50.0%
|
-
|
|
Feb 03
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,255
-100.0%
|
$43,925
$35.11 P/Share
|
|
Feb 03
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,255
+45.26%
|
$12,550
$10.64 P/Share
|
|
Jan 03
2023
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,339
+38.19%
|
-
|
|
Jan 03
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,500
-100.0%
|
$77,500
$31.11 P/Share
|
|
Jan 03
2023
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$37,500
$15.0 P/Share
|